Exogenesis Surgical Mask reaches primary endpoints in Covid-19 deactivation challenge trials

Exogenesis Surgical Mask reaches primary endpoints in Covid-19 deactivation challenge trials. (Credit: Gerd Altmann from Pixabay)



Related Article
Recommended Whitepaper

View More